Monetization

Trial Conversion Rate

Also known asTrial-to-Paid ConversionTrial Conversion

The percentage of users who start a free trial and then continue into the first paid period — the central unit-economics metric for subscription apps.

Key takeaways

  1. 01Trial conversion rate = paid first-period conversions ÷ trial starts.
  2. 02Industry medians: productivity 30-50%, entertainment / dating 50-70%, F2P sub tiers 15-30%. Great apps hit 60%+.
  3. 03Trial conversion ratio doubles the effective CPI ceiling — 40% vs 25% conversion changes UA economics fundamentally.
  4. 04Levers in order of impact: post-trial price clarity, pre-trial onboarding quality, push around trial end, in-trial engagement.

Trial conversion rate is the central unit-economics metric for a subscription app. The formula: paid first-period conversions ÷ trial starts. A 7-day trial ending in a $9.99 / month charge with 40% conversion is a fundamentally different business than the same trial at 25% — the first-month gross revenue per trial start doubles ($4 vs $2.50), which doubles the effective CPI ceiling you can sustainably bid into paid acquisition.

Industry medians vary wildly by vertical

Great apps in any vertical land at 60%+ trial-to-paid.

Levers that move trial conversion (ranked by typical impact):

  1. Post-trial price clarity on the paywall. Apple requires disclosure; the apps that lead with the trial offer AND clearly show the post-trial subscription price convert better than apps that bury the price. Vague disclosure lifts trial starts (because users don't see the commitment) but tanks conversion at the step-up.
  2. Pre-trial onboarding quality. Users who complete the full onboarding before starting the trial convert 2-3× higher. Time the trial start AFTER a meaningful aha moment, not before.
  3. In-trial engagement nudges. Push / email around trial end ("your trial ends in 24 hours") typically lifts conversion 5-15%.
  4. In-trial usage signal. Users active in the last 48 hours of trial convert 3-5× higher than users who haven't opened the app since day 1. Track this; engage the inactive cohort specifically.

Common pitfall: optimizing trial-START rate at the expense of trial-conversion rate. A paywall variant that yields 20% more trial starts but 30% fewer conversions has worse downstream economics, even though the top-of-funnel number looks great. Always measure both rates and let net-revenue-per-paywall-impression be the optimization metric, not start rate alone.

Quick answers

What is a good trial-to-paid conversion rate?

Industry medians: consumer productivity / utilities 30-50%, entertainment / dating 50-70%, F2P subscription tiers 15-30%. Great apps in any vertical land at 60%+. Compare against your historical baseline rather than industry averages — paywall design and pricing tier matter more than category.

How do you calculate trial-to-paid conversion rate?

Paid first-period conversions ÷ trial starts. Count trial starts at the moment the user enrolls in the trial (the StoreKit / Google Play Billing event); count paid conversions when the platform fires the first non-trial billing event. Be careful with refunds — most analytics tools count converted-then-refunded as "did not convert" for monetization reporting.

What is the difference between trial conversion and paywall conversion?

**Paywall conversion** = trial starts ÷ paywall impressions (typically 5-15%). **Trial conversion** = paid conversions ÷ trial starts (typically 30-50%). Multiply them together to get paywall-impression-to-paid (typically 2-7%). The two metrics are independent levers — you can lift one without moving the other, and the optimal strategy depends on which is your bottleneck.

Why does my trial conversion drop after I increase the trial length?

Longer trials lift trial starts (lower commitment friction) but typically lower trial-to-paid conversion at the step-up (more time for engagement to fade, more users who started for free without real intent). The net effect on paid users can be positive or negative depending on your product. A/B test trial-length variants and measure the integrated impact — don't assume "more trial = more revenue".

Back to glossary